国家出台患者救治、医护补助、防疫物资保障三方面补助政策

2020-02-03 田晓航、白瀛 新华视点

国家卫健委副主任李斌在国新办3日举行的新闻发布会上说,财政部、人社部、国家医保局、国家卫健委围绕患者救治、医务人员补助、防疫物资保障三方面出台相关政策:一是明确患者救治费用的补助政策,对于确诊患者发生的医疗费用, 在基本医保、大病保险、医疗救助等按规定支付后,个人负担的部分由中央和地方财政给予补助;二是对参加防治工作的医务人员和防疫工作者发放临时性工作补助,中央和地方按规定标准安排经费,明确在疫情

国家卫健委副主任李斌在国新办3日举行的新闻发布会上说,财政部、人社部、国家医保局、国家卫健委围绕患者救治、医务人员补助、防疫物资保障三方面出台相关政策:一是明确患者救治费用的补助政策,对于确诊患者发生的医疗费用, 在基本医保、大病保险、医疗救助等按规定支付后,个人负担的部分由中央和地方财政给予补助;二是对参加防治工作的医务人员和防疫工作者发放临时性工作补助,中央和地方按规定标准安排经费,明确在疫情防治和救治工作中,医护及相关工作人员因履行工作职责感染新型冠状病毒的,应认定为工伤,依法享受工伤保险待遇;三是医疗卫生机构开展疫情防控工作所需防护、诊断、治疗专用设备以及快速诊断试剂采购所需经费,由地方财政予以安排,中央财政视情况予以保障。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2076616, encodeId=a5aa20e661642, content=<a href='/topic/show?id=3bba530432c' target=_blank style='color:#2F92EE;'>#患者救治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53043, encryptionId=3bba530432c, topicName=患者救治)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70fe497, createdName=paperyu, createdTime=Sat Aug 15 18:34:00 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756584, encodeId=77491e565846d, content=<a href='/topic/show?id=552d9e45639' target=_blank style='color:#2F92EE;'>#防疫物资#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97456, encryptionId=552d9e45639, topicName=防疫物资)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d78137191735, createdName=ms2999106592497887, createdTime=Sun Dec 20 18:34:00 CST 2020, time=2020-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260475, encodeId=ba4a12604e5a0, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Wed Feb 05 13:34:00 CST 2020, time=2020-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402581, encodeId=4d891402581e3, content=<a href='/topic/show?id=546f9e45197' target=_blank style='color:#2F92EE;'>#防疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97451, encryptionId=546f9e45197, topicName=防疫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf7e2418349, createdName=zhangying8789, createdTime=Wed Feb 05 13:34:00 CST 2020, time=2020-02-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2076616, encodeId=a5aa20e661642, content=<a href='/topic/show?id=3bba530432c' target=_blank style='color:#2F92EE;'>#患者救治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53043, encryptionId=3bba530432c, topicName=患者救治)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70fe497, createdName=paperyu, createdTime=Sat Aug 15 18:34:00 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756584, encodeId=77491e565846d, content=<a href='/topic/show?id=552d9e45639' target=_blank style='color:#2F92EE;'>#防疫物资#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97456, encryptionId=552d9e45639, topicName=防疫物资)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d78137191735, createdName=ms2999106592497887, createdTime=Sun Dec 20 18:34:00 CST 2020, time=2020-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260475, encodeId=ba4a12604e5a0, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Wed Feb 05 13:34:00 CST 2020, time=2020-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402581, encodeId=4d891402581e3, content=<a href='/topic/show?id=546f9e45197' target=_blank style='color:#2F92EE;'>#防疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97451, encryptionId=546f9e45197, topicName=防疫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf7e2418349, createdName=zhangying8789, createdTime=Wed Feb 05 13:34:00 CST 2020, time=2020-02-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2076616, encodeId=a5aa20e661642, content=<a href='/topic/show?id=3bba530432c' target=_blank style='color:#2F92EE;'>#患者救治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53043, encryptionId=3bba530432c, topicName=患者救治)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70fe497, createdName=paperyu, createdTime=Sat Aug 15 18:34:00 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756584, encodeId=77491e565846d, content=<a href='/topic/show?id=552d9e45639' target=_blank style='color:#2F92EE;'>#防疫物资#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97456, encryptionId=552d9e45639, topicName=防疫物资)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d78137191735, createdName=ms2999106592497887, createdTime=Sun Dec 20 18:34:00 CST 2020, time=2020-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260475, encodeId=ba4a12604e5a0, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Wed Feb 05 13:34:00 CST 2020, time=2020-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402581, encodeId=4d891402581e3, content=<a href='/topic/show?id=546f9e45197' target=_blank style='color:#2F92EE;'>#防疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97451, encryptionId=546f9e45197, topicName=防疫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf7e2418349, createdName=zhangying8789, createdTime=Wed Feb 05 13:34:00 CST 2020, time=2020-02-05, status=1, ipAttribution=)]
    2020-02-05 bioon3
  4. [GetPortalCommentsPageByObjectIdResponse(id=2076616, encodeId=a5aa20e661642, content=<a href='/topic/show?id=3bba530432c' target=_blank style='color:#2F92EE;'>#患者救治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53043, encryptionId=3bba530432c, topicName=患者救治)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70fe497, createdName=paperyu, createdTime=Sat Aug 15 18:34:00 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756584, encodeId=77491e565846d, content=<a href='/topic/show?id=552d9e45639' target=_blank style='color:#2F92EE;'>#防疫物资#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97456, encryptionId=552d9e45639, topicName=防疫物资)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d78137191735, createdName=ms2999106592497887, createdTime=Sun Dec 20 18:34:00 CST 2020, time=2020-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260475, encodeId=ba4a12604e5a0, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Wed Feb 05 13:34:00 CST 2020, time=2020-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402581, encodeId=4d891402581e3, content=<a href='/topic/show?id=546f9e45197' target=_blank style='color:#2F92EE;'>#防疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97451, encryptionId=546f9e45197, topicName=防疫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf7e2418349, createdName=zhangying8789, createdTime=Wed Feb 05 13:34:00 CST 2020, time=2020-02-05, status=1, ipAttribution=)]